[HTML][HTML] Propionibacterium acnes CAMP Factor and Host Acid Sphingomyelinase Contribute to Bacterial Virulence: Potential Targets for Inflammatory Acne Treatment

T Nakatsuji, DC Tang, L Zhang, RL Gallo, CM Huang - PloS one, 2011 - journals.plos.org
T Nakatsuji, DC Tang, L Zhang, RL Gallo, CM Huang
PloS one, 2011journals.plos.org
Background In the progression of acne vulgaris, the disruption of follicular epithelia by an
over-growth of Propionibacterium acnes (P. acnes) permits the bacteria to spread and
become in contact with various skin and immune cells. Methodology/Principal Findings We
have demonstrated in the present study that the Christie, Atkins, Munch-Peterson (CAMP)
factor of P. acnes is a secretory protein with co-hemolytic activity with sphingomyelinase that
can confer cytotoxicity to HaCaT keratinocytes and RAW264. 7 macrophages. The CAMP …
Background
In the progression of acne vulgaris, the disruption of follicular epithelia by an over-growth of Propionibacterium acnes (P. acnes) permits the bacteria to spread and become in contact with various skin and immune cells.
Methodology/Principal Findings
We have demonstrated in the present study that the Christie, Atkins, Munch-Peterson (CAMP) factor of P. acnes is a secretory protein with co-hemolytic activity with sphingomyelinase that can confer cytotoxicity to HaCaT keratinocytes and RAW264.7 macrophages. The CAMP factor from bacteria and acid sphingomyelinase (ASMase) from the host cells were simultaneously present in the culture supernatant only when the cells were co-cultured with P. acnes. Either anti-CAMP factor serum or desipramine, a selective ASMase inhibitor, significantly abrogated the P. acnes-induced cell death of HaCaT and RAW264.7 cells. Intradermal injection of ICR mouse ears with live P. acnes induced considerable ear inflammation, macrophage infiltration, and an increase in cellular soluble ASMase. Suppression of ASMase by systemic treatment with desipramine significantly reduced inflammatory reaction induced by intradermal injection with P. acnes, suggesting the contribution of host ASMase in P. acnes-induced inflammatory reaction in vivo. Vaccination of mice with CAMP factor elicited a protective immunity against P. acnes-induced ear inflammation, indicating the involvement of CAMP factor in P. acnes-induced inflammation. Most notably, suppression of both bacterial CAMP factor and host ASMase using vaccination and specific antibody injection, respectively, cooperatively alleviated P. acnes-induced inflammation.
Conclusions/Significance
These findings envision a novel infectious mechanism by which P. acnes CAMP factor may hijack host ASMase to amplify bacterial virulence to degrade and invade host cells. This work has identified both CAMP factor and ASMase as potential molecular targets for the development of drugs and vaccines against acne vulgaris.
PLOS